VANGUARD GROUP INC

Holdings History for Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK)

Symbol: OTLK on Nasdaq
Investment type: Equity / Common Stock, par value $0.01 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$2,314,964	1,465,167	+122,540	+9.1%	$1.58	Q4 2025
30 Sep 2025	0%	+0%	$1,423,185	1,342,627	+91,029	+7.3%	$1.06	Q3 2025
30 Jun 2025	0%	+0%	$2,002,557	1,251,598	+414,191	+49%	$1.60	Q2 2025
31 Mar 2025	0%	0%	$1,021,637	837,407	-15,133		$1.22	Q1 2025
31 Dec 2024	0%	0%	$1,611,300	852,540	-3,336	-0.39%	$1.89	Q4 2024
30 Sep 2024	0%	+0%	$4,570,378	855,876	+308,103	+56%	$5.34	Q3 2024
30 Jun 2024	0%	+0%	$4,042,565	547,773	+206,473	+60%	$7.38	Q2 2024
31 Mar 2024	0%	+0%	$4,075,122	341,300	+341,300	NEW	$11.94	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.